Lv5
803 积分 2021-08-19 加入
Sheehan syndrome
1个月前
已完结
Long-term Cardiovascular, Renal, and Safety Outcomes of Teprotumumab versus Systemic Glucocorticoids in Thyroid Eye Disease
1个月前
已完结
Chronic kidney disease
2个月前
已完结
Does gouty nephropathy exist, and is it more common than we think?
2个月前
已完结
Comprehensive analysis of therapeutic strategies for Gouty nephropathy: Insights from clinical trials
2个月前
已完结
New weight loss pill outperforms oral semaglutide for diabetes patients, study reports
3个月前
已关闭
Oral Semaglutide in Adults with Overweight or Obesity
3个月前
已完结
No More Needles: Oral Semaglutide for Weight Loss
3个月前
已完结
Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity
3个月前
已完结
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
3个月前
已完结
皖公网安备34019202002308
